Measurement of Neonatal Microvascular Hemodynamics Using Non-invasive Optical Technologies
Status
Conditions
Treatments
Details and patient eligibility
About
Alterations to microvascular blood flow in premature infants, are known to contribute to several major disease entities.
The optically-measured tissue blood flow, to determine tissue perfusion that can be use to detect blood loss.
Full description
The researchers want to use optical technologies to non-invasively detect blood flow that can tell the onset of blood loss. The research can measure blood flow in stable premature infants in the Neonatal Intensive Care Unit over the duration of several weeks.
The technologies are Laser Speckle Imaging and Diffuse Optical Spectroscopy.
Laser Speckle Imaging non-contact imaging technology, is sensitive to blood flow in superficial tissues. Diffuse Optical Spectroscopy, a probe-based contact technology like pulse oximetry, measures hemoglobin concentrations and states deeper below the skin surface.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- premature infants born or transferred to neonatal intensive care unit with a gestational age of 28-35 weeks
Exclusion criteria
- NONE premature infants born or transferred to neonatal intensive care unit
Trial design
32 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal